Swiss HIV Cohort Study
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
Wang Q, Battegay M, Bucher H, Fehr J, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Young J, Swiss HIV Cohort Study. Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV Clin Trials 2014; 15:92-103.
01.05.2014Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
01.05.2014HIV Clin Trials 2014; 15:92-103
Wang Qing, Battegay Manuel, Bucher Heiner C, Fehr Jan, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Furrer H, Bernasconi E, Fux C, Wang Q, Swiss HIV Cohort Study. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV Med 2014; 15:505-10.
18.03.2014The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir
18.03.2014HIV Med 2014; 15:505-10
Young J, Bucher H C, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza Pietro, Furrer H, Bernasconi E, Fux C A, Wang Q, Swiss HIV Cohort Study
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
Hasse B, Ledergerber B, Weber R, Di Benedetto C, Fellay J, Calmy A, Battegay M, Hoffmann M, Furrer H, Fehr J, Walker A, Swiss HIV Cohort Study. Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. Antimicrob Agents Chemother 2014; 58:2363-8.
10.02.2014Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
10.02.2014Antimicrob Agents Chemother 2014; 58:2363-8
Hasse Barbara, Ledergerber Bruno, Weber Rainer, Di Benedetto Caroline, Fellay Jacques, Calmy Alexandra, Battegay Manuel, Hoffmann Matthias, Furrer Hansjakob, Fehr Jan, Walker A Sarah, Swiss HIV Cohort Study
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
Drescher S, Kouyos R, Günthard H, Ledergerber B, Vernazza P, Bernasconi E, Cavassini M, Ambrosioni J, Battegay M, Furrer H, Taffé P, Klimkait T, Aubert V, Shah C, Yerly S, Böni J, Yang W, von Wyl V, Swiss HIV Cohort Study. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clin Infect Dis 2013; 58:285-94.
21.10.2013Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study
21.10.2013Clin Infect Dis 2013; 58:285-94
Drescher Sara M, Kouyos Roger D, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Bernasconi Enos, Cavassini Matthias, Ambrosioni Juan, Battegay Manuel, Furrer Hansjakob, Taffé Patrick, Klimkait Thomas, Aubert Vincent, Shah Cyril, Yerly Sabine, Böni Jürg, Yang Wan-Lin, von Wyl Viktor, Swiss HIV Cohort Study
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
von Wyl V, Glass T, Bucher H, Günthard H, Aubert V, Böni J, Bernasconi E, Calmy A, Cavassini M, Furrer H, Nicca D, Yerly S, Klimkait T, Swiss HIV Cohort Study. Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PloS one 2013; 8:e77691.
16.10.2013Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
16.10.2013PloS one 2013; 8:e77691
von Wyl Viktor, Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Aubert Vincent, Böni Jürg, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Nicca Dunja, Yerly Sabine, Klimkait Thomas, Swiss HIV Cohort Study
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
Beerenwinkel N, Günthard H, Cellerai C, Klimkait T, Böni J, Yerly S, Bernasconi E, Vernazza P, Cavassini M, Hirschel B, Battegay M, Furrer H, von Wyl V, Knupfer P, Schuhmacher H, Montazeri H, Swiss HIV Cohort Study. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients. PLoS Comput Biol 2013; 9:e1003203.
29.08.2013The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients
29.08.2013PLoS Comput Biol 2013; 9:e1003203
Beerenwinkel Niko, Günthard Huldrych F, Cellerai Cristina, Klimkait Thomas, Böni Jürg, Yerly Sabine, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Hirschel Bernard, Battegay Manuel, Furrer Hansjakob, von Wyl Viktor, Knupfer Patrick, Schuhmacher Heike, Montazeri Hesam, Swiss HIV Cohort Study
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
Wandeler G, Rauch A, Furrer H, Egger M, Calmy A, Battegay M, Schmid P, Kovari H, Cavassini M, Bernasconi E, Bihl F, Gsponer T, Swiss HIV Cohort Study. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J Infect Dis 2013; 208:1454-8.
30.07.2013Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
30.07.2013J Infect Dis 2013; 208:1454-8
Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Egger Matthias, Calmy Alexandra, Battegay Manuel, Schmid Patrick, Kovari Helen, Cavassini Matthias, Bernasconi Enos, Bihl Florian, Gsponer Thomas, Swiss HIV Cohort Study
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Metzner K, Aubert V, Furrer H, Battegay M, Vernazza P, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard H, Klimkait T, Yerly S, Böni J, Scherrer A, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Swiss HIV Cohort Study. Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis 2013; 208:1102-12.
11.07.2013Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
11.07.2013J Infect Dis 2013; 208:1102-12
Metzner Karin J, Aubert Vincent, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Weber Rainer, Günthard Huldrych F, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Preiswerk Benjamin, Joos Beda, von Wyl Viktor, Leemann Christine, Rieder Philip, Braun Dominique, Grube Christina, Kuster Herbert, Swiss HIV Cohort Study
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
Nüesch R, Bucher H, Battegay M, Calmy A, Thurnheer M, Vernazza P, Cavassini M, Weber R, Bernasconi E, Elzi L, Wang Q, Swiss HIV Cohort Study. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr 2013; 62:396-404.
01.04.2013Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
01.04.2013J Acquir Immune Defic Syndr 2013; 62:396-404
Nüesch Reto, Bucher Heiner C, Battegay Manuel, Calmy Alexandra, Thurnheer Maria C, Vernazza Pietro, Cavassini Matthias, Weber Rainer, Bernasconi Enos, Elzi Luigia, Wang Qing, Swiss HIV Cohort Study
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Du Pasquier R, Vernazza P, Cavassini M, Günthard H, Cusini A, Gutmann C, Fux C, Yerly S, Kalubi M, Jilek S, Swiss HIV Cohort Study. Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS 2013; 27:203-10.
14.01.2013Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
14.01.2013AIDS 2013; 27:203-10
Du Pasquier Renaud A, Vernazza Pietro, Cavassini Matthias, Günthard Huldrych F, Cusini Alexia, Gutmann Christine, Fux Christoph A, Yerly Sabine, Kalubi Malela, Jilek Samantha, Swiss HIV Cohort Study
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
Cusini A, Günthard H, Opravil M, Gutmann C, Zenger F, Klimkait T, Cavassini M, Gaudenz R, Hirschel B, Widmer N, Rohrbach J, Fux C, Ledergerber B, Decosterd L, Yerly S, Vernazza P, Swiss HIV Cohort Study. Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr 2013; 62:28-35.
01.01.2013Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid
01.01.2013J Acquir Immune Defic Syndr 2013; 62:28-35
Cusini Alexia, Günthard Huldyrich F, Opravil Milos, Gutmann Christine, Zenger Franziska, Klimkait Thomas, Cavassini Matthias, Gaudenz Roman, Hirschel Bernhard, Widmer Nicolas, Rohrbach Janine, Fux Christoph A, Ledergerber Bruno, Decosterd Laurent A, Yerly Sabine, Vernazza Pietro, Swiss HIV Cohort Study
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study
van Sighem A, Low N, Fraser C, Bezemer D, Jeannin A, Derendinger S, de Wolf F, Gebhardt M, Vernazza P, Bucher H, Glass T, Vidondo B, Swiss HIV Cohort Study. Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PloS one 2012; 7:e44819.
14.09.2012Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study
14.09.2012PloS one 2012; 7:e44819
van Sighem Ard, Low Nicola, Fraser Christophe, Bezemer Daniela, Jeannin Andre, Derendinger Steven, de Wolf Frank, Gebhardt Martin, Vernazza Pietro, Bucher Heiner C, Glass Tracy R, Vidondo Beatriz, Swiss HIV Cohort Study
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
Wang Q, Fux C, Bucher H, Stoeckle M, Furrer H, Weber R, Hirschel B, Vernazza P, Cavassini M, Bernasconi E, Young J, Swiss HIV Cohort Study. The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antivir Ther (Lond) 2012; 18:337-44.
12.09.2012The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
12.09.2012Antivir Ther (Lond) 2012; 18:337-44
Wang Qing, Fux Christoph, Bucher Heiner C, Stoeckle Marcel, Furrer Hansjakob, Weber Rainer, Hirschel Bernard, Vernazza Pietro, Cavassini Matthias, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
Wandeler G, Rauch A, Furrer H, Bernasconi E, Stöckle M, Calmy A, Clerc O, Günthard H, Bregenzer A, Gsponer T, Swiss HIV Cohort Study. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012; 55:1408-16.
14.08.2012Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
14.08.2012Clin Infect Dis 2012; 55:1408-16
Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Bernasconi Enos, Stöckle Marcel, Calmy Alexandra, Clerc Olivier, Günthard Huldrych F, Bregenzer Andrea, Gsponer Thomas, Swiss HIV Cohort Study
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Cellerai C, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PloS one 2012; 7:e37983.
18.06.2012Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
18.06.2012PloS one 2012; 7:e37983
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Cellerai Cristina, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
Pillai S, Wong J, Günthard H, Ledergerber B, Bernasconi E, Bregenzer A, Hirschel B, Battegay M, Fellay J, Rauch A, Kovari H, Greene W, Yukl S, Fujimoto K, Monto A, Skasko M, Guatelli J, Abdel-Mohsen M, Swiss HIV Cohort Study. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci USA 2012; 109:3035-40.
06.02.2012Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
06.02.2012Proc Natl Acad Sci USA 2012; 109:3035-40
Pillai Satish K, Wong Joseph K, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Bregenzer Andrea, Hirschel Bernard, Battegay Manuel, Fellay Jacques, Rauch Andri, Kovari Helen, Greene Warner C, Yukl Steven, Fujimoto Katsuya, Monto Alexander, Skasko Mark, Guatelli John, Abdel-Mohsen Mohamed, Swiss HIV Cohort Study
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis
Keiser O, Egger M, Ledergerber B, Nicca D, Glass T, Cavassini M, Calmy A, Rauch A, Spycher B, Swiss HIV Cohort Study. Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis. AIDS Behav 2012; 16:245-55.
01.02.2012Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis
01.02.2012AIDS Behav 2012; 16:245-55
Keiser Olivia, Egger Matthias, Ledergerber Bruno, Nicca Dunja, Glass Tracy R, Cavassini Matthias, Calmy Alexandra, Rauch Andri, Spycher Ben, Swiss HIV Cohort Study
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
Clifford G, Schöni-Affolter F, Keiser O, Calmy A, Cavassini M, Bernasconi E, Battegay M, Schmid P, Fehr J, Wandeler G, Jundt G, Ess S, Levi F, Korol D, Bouchardy C, Egger M, Franceschi S, Lise M, Swiss HIV Cohort Study. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012; 106:447-52.
12.01.2012Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
12.01.2012Br J Cancer 2012; 106:447-52
Clifford G M, Schöni-Affolter F, Keiser O, Calmy A, Cavassini M, Bernasconi E, Battegay M, Schmid Patrick, Fehr J, Wandeler G, Jundt G, Ess S, Levi F, Korol D, Bouchardy C, Egger M, Franceschi S, Lise M, Swiss HIV Cohort Study
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study
Staehelin C, Furrer H, Bernasconi E, Schmid P, Cavassini M, Elzi L, Weber R, Calmy A, Keiser O, Swiss HIV Cohort Study. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2012; 59:79-85.
01.01.2012Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study
01.01.2012J Acquir Immune Defic Syndr 2012; 59:79-85
Staehelin Cornelia, Furrer Hansjakob, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Elzi Luigia, Weber Rainer, Calmy Alexandra, Keiser Olivia, Swiss HIV Cohort Study
A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA
Wandeler G, Furrer H, Vernazza P, Clerc O, Battegay M, Bernasconi E, Günthard H, Hirschel B, Keiser O, Swiss HIV Cohort Study. A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PloS one 2011; 6:e27903.
20.12.2011A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA
20.12.2011PloS one 2011; 6:e27903
Wandeler Gilles, Furrer Hansjakob, Vernazza Pietro, Clerc Olivier, Battegay Manuel, Bernasconi Enos, Günthard Huldrych F, Hirschel Bernard, Keiser Olivia, Swiss HIV Cohort Study